Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF ATOPIC DERMATITIS CONTAINING IL-31 ANTAGONIST AS ACTIVE INGREDIENT
Document Type and Number:
WIPO Patent Application WO/2016/167263
Kind Code:
A1
Abstract:
In a non-limiting embodiment, a pharmaceutical composition for the prevention and/or treatment of atopic dermatitis is provided, the pharmaceutical composition containing an IL-31 antagonist as an active ingredient, wherein 0.1-1000 mg/body/1 day-12 weeks, preferably 0.1-1000 mg/body/2 weeks, 0.1-1000 mg/body/4 weeks, or 0.1-1000 mg/body/8 weeks, of the IL-31 antagonist is repeatedly administered in equal amounts at the same dosing interval to a subject who has contracted or is at risk for contracting atopic dermatitis.

Inventors:
KANEKO AKIHISA (JP)
IWAYANAGI YUKI (JP)
KITAMURA HIDETOMO (JP)
HIGUCHI YOSHINOBU (JP)
MATSUSHITA HIROAKI (JP)
MIHARA RYOSUKE (JP)
YAMAMOTO YUMI (JP)
SAITO TOMOHISA (JP)
HIROKAWA KEIKO (JP)
Application Number:
PCT/JP2016/061859
Publication Date:
October 20, 2016
Filing Date:
April 13, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CHUGAI PHARMACEUTICAL CO LTD (JP)
International Classes:
A61K45/00; A61K39/395; A61P17/00; A61P17/04; A61P25/20; C07K16/24; C07K16/28
Domestic Patent References:
WO2010064697A12010-06-10
WO2014208645A12014-12-31
WO2009041643A12009-04-02
Other References:
OSAMU NEMOTO ET AL.: "Kenko Seijin Dansei Oyobi Atopy-sei Hifuen Kanja o Taisho to shita IL -31 Juyotai Kotai CIM331 no Dai I-So Shiken", JAPANESE JOURNAL OF DERMATOLOGY, vol. 124, no. 4, 2014, pages 779, XP055492052
See also references of EP 3284480A4
Attorney, Agent or Firm:
HARUNA, Masao et al. (JP)
Masao Haruna (JP)
Download PDF:



 
Previous Patent: SLIDING PARTS

Next Patent: ELECTRONIC PEN